HOXB13 promotes ovarian cancer progression

Deregulated expression of HOXB13 in a subset of estrogen receptor-positive breast cancer patients treated with tamoxifen monotherapy is associated with an aggressive clinical course and poor outcome. Because the ovary is another hormone-responsive organ, we investigated whether HOXB13 plays a role i...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Miao, Jiangyong, Wang, Zuncai, Provencher, Heather, Muir, Beth, Dahiya, Sonika, Carney, Erin, Leong, Chee-Onn, Sgroi, Dennis C., Orsulic, Sandra
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: National Academy of Sciences 2007
Gaiak:
Biological Sciences
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2040435/
https://ncbi.nlm.nih.gov/pubmed/17942676
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0707938104
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak